Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia

Neurology

Volumn 68, Issue 6, 2007, Pages 438-445

  Chandra, P S ^a,c   Salamon, N ^a   Nguyen, S T ^a   Chang, J W ^a   Huynh, M N ^a   Cepeda, C ^a   Leite, J P ^b   Neder, L ^b   Koh, S ^a   Vinters, H V ^a   Mathern, G W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOPSY; BRAIN SIZE; CELL DENSITY; CELL NUCLEUS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL DYSPLASIA; DISEASE ASSOCIATION; GRAY MATTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANTILE SPASM; MICROCEPHALY; MONOZYGOTIC TWINS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SURGICAL PATIENT; TUBEROUS SCLEROSIS; WHITE MATTER;

CEREBRAL CORTEX; CHILD; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MICROCEPHALY; SPASMS, INFANTILE; TUBEROUS SCLEROSIS;

EID: 33846798050     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000252952.62543.20     Document Type: Article

References (49)

1. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 2002;12:212-233.
2. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873-1887.
3. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-153.
4. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971;34:369-387.
5. Vinters HV, Kerfoot C, Catania M, et al. Tuberous sclerosis-related gene expression in normal and dysplastic brain. Epilepsy Res. 1998;32:12-23.
6. Becker AJ, Urbach H, Scheffler B, et al. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002;52:29-37.
7. Majores M, Blumcke I, Urbach H, et al. Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cells. J Neuropathol Exp Neurol 2005;64:629-637.
8. Wolf HK, Normann S, Green AJ, et al. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions. Acta Neuropathol (Berl) 1997;93:93-96.
9. White R, Hua Y, Scheithauer B, et al. Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 2001;49:67-78.
10. Crino PB. Bourneville and Taylor: a developing story? Ann Neurol 2002;52:6-9.
11. Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56:478-487.
12. Miyata H, Chiang AC, Vinters HV. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 2004;56:510-519.
13. Vinters HV, Park SH, Johnson MW, et al. Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes. Dev Neurosci. 1999;21:248-259.
14. Johnson MW, Emelin JK, Park SH, Vinters HV. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis. Brain Pathol 1999;9:45-54.
15. Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006;59:490-498.
16. Andres M, Andre VM, Nguyen S, et al. Human cortical dysplasia and epilepsy: an ontogenetic hypothesis based on volumetric MRI and NeuN neuronal density and size measurements. Cereb Cortex 2005;15:194-210.
17. Salamon N, Andres M, Chute DJ, et al. Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephaly. Brain 2006;129:352-365.
18. Caviness VS Jr, Goto T, Tarui T, et al. Cell output, cell cycle duration and neuronal specification: a model of integrated mechanisms of the neocortical proliferative process. Cereb Cortex 2003;13:592-598.
19. Caviness VS, Jr, Takahashi T, Nowakowski RS. Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. Trends Neurosci 1995;18:379-383.
20. Miyata H, Chute DJ, Fink J, Villablanca P, Vinters HV. Lissencephaly with agenesis of corpus callosum and rudimentary dysplastic cerebellum: a subtype of lissencephaly with cerebellar hypoplasia. Acta Neuropathol (Berl) 2004;107:69-81.
21. Cepeda C, Andre VM, Levine MS, et al. Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav 2006;9:219-235.
22. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628.
23. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology 2004;62(suppl 3):S2-S8.
24. Mathern GW, Giza CC, Yudovin S, et al. Postoperative seizure control and antiepileptic drug use in pediatric epilepsy surgery patients: the UCLA experience, 1986-1997. Epilepsia 1999;40:1740-1749.
25. Jonas R, Nguyen S, Hu B, et al. Cerebral hemispherectomy: hospital course, seizure, developmental, language, and motor outcomes. Neurology 2004;62:1712-1721.
26. Chandra PS, Salamon N, Huang J, et al. FDG-PET/MRI co-registration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report. Epilepsia 2006;47:1543-1549.
27. Wu JY, Sutherling WW, Koh S, et al. Magnetic source imaging localizes epileptogenic zone in children with tuberous sclerosis complex. Neurology 2006;66:1270-1272.
28. Jonas R, Asarnow RF, LoPresti C, et al. Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology 2005;64:746-750.
29. Cepeda C, Andre VM, Flores-Hernandez J, et al. Pediatric cortical dysplasia: Correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells, and glutamate/GABA synaptic circuits. Dev Neurosci 2005;27:59-76.
30. Mathern GW, Babb TL, Pretorius JK, Leite JP. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci 1995;15:3990-4004.
31. Mathern GW, Kuhlman PA, Mendoza D, Pretorius JK. Human fascia dentata anatomy and hippocampal neuron densities differ depending on the epileptic syndrome and age at first seizure. J Neuropathol Exp Neurol 1997;56:199-212.
32. Cook SW, Nguyen ST, Hu B, et al. Cerebral hemispherectomy for pediatric epilepsy patients: a comparison of three techniques by pathologic substrate in 115 patients. J Neurosurg 2004;100:125-141.
33. DiMario FJ Jr.. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 2004;19:650-657.
34. Bolton PF, Griffiths PD. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 1997;349:392-395.
35. Ridler K, Bullmore ET, De Vries PJ, et al. Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychol Med 2001;31:1437-1446.
36. Ridler K, Suckling J, Higgins NJ, et al. Neuroanatomical correlates of memory deficits in tuberous sclerosis complex. Cereb Cortex 2006 (Epub April 7).
37. Andre VM, Flores-Hernandez J, Cepeda C, et al. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex 2004;14:634-646.
38. Cepeda C, Hurst RS, Flores-Hernandez J, et al. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003;72:472-486.
39. Cepeda C, Andre VM, Vinters HV, Levine MS, Mathern GW. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia. 2005;46(suppl 5):82-88.
40. Cepeda C, Andre VM, Wu N, et al. Immature neurons and networks may contribute to epileptogenesis in pediatric cortical dysplasia. Epilepsia 2006 (in press).
41. Rantala H, Shields WD, Christenson PD, et al. Risk factors of infantile spasms compared with other seizures in children under 2 years of age. Epilepsia 1996;37:362-366.
42. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996;37:367-372.
43. Cohen JA, Fisher RS, Brigell MG, Peyster RG, Sze G. The potential for vigabatrin-induced intramyelinic edema in humans. Epilepsia 2000;41:148-157.
44. Van Paesschen W, Duncan JS, Connelly A. A comparison of the neuropathological effects of vigabatrin and carbamazepine in patients with newly diagnosed localization-related epilepsy using MR-based cerebral T2 relaxation time measurements. Epilepsy Res 1998;29:155-160.
45. Qiao M, Malisza KL, Del Bigio MR, et al. Effect of long-term vigabatrin administration on the immature rat brain. Epilepsia 2000;41:655-665.
46. Sidhu RS, Del Bigio MR, Tuor UI, Seshia SS. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain. Exp Neurol 1997;144:400-405.
47. Goh S, Kwiatkowski DJ, Dorer DJ, Thiele EA. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 2005;65:235-238.
48. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773-1778.
49. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005;4:712-717.